{
    "code": "02024379",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024379",
    "time": "2019-06-07 03:04:24",
    "許可證字號": "衛署藥輸字第024379號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/02\/14",
    "發證日期": "95\/02\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202437901",
    "中文品名": "安保喜樂膜衣錠 40毫克",
    "英文品名": "Apo-Citalopram Film-coated Tablets 40mg",
    "適應症": "內因和外因性抑鬱症。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000粒塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "CITALOPRAM HYDROBROMIDE",
    "主製造廠": {
        "申請商名稱": "6217064612  鴻汶醫藥實業有限公司",
        "申請商地址": "台中市西屯區文心路三段236號3樓、238號3樓",
        "主製造廠": "",
        "製造廠名稱": "FCA0025000  APOTEX INC."
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200035510",
            "成分名稱": "CITALOPRAM HYDROBROMIDE",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Apo-Citalopram 安保喜樂膜衣錠_40 mg_20160908-105-09-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024379&Seq=007&Type=9"
        },
        {
            "title": "APO-CITA 40MG-100BTL-105-05-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024379&Seq=002&Type=8"
        }
    ]
}